Claims
- 1. A method of detecting at least one of a probe and a target substance capable of specifically binding to the probe disposed on a substrate, the method comprising the steps of:
preparing a substrate having at least one of a probe and a target substance specifically bonded to the probe disposed on a surface thereof; and measuring the surface of the substrate by the Time-of-Flight Secondary Ion Mass Spectrometry, wherein at least one of the probe and the target substance is labeled with a marker substance capable of forming a fragment ion that is not formed by fragmentation of the at least one of the probe and the target substance.
- 2. A method comprising reacting a sample with a probe carrier having a number of probe-immobilized regions disposed independently in a matrix pattern on a carrier and analyzing an analysis sample (carrier) obtained by the reaction, wherein a target substance in the sample capable of specifically binding to the probe is labeled with a halogen atom and formation/unformation of a complex obtained by the reaction between the probe and the target substance is detected by measuring the halogen atom by the Time-of-Flight Secondary Ion Mass Spectrometry.
- 3. A method of analyzing a probe carrier having a number of probe-immobilized regions disposed in a matrix pattern on a carrier by the Time-of-Flight Secondary Ion Mass Spectrometry, which comprises labeling the probes with halogen atoms and detecting fragment ions of the halogen atoms to analyze the state of the probe.
- 4. The method according to claim 2 or 3, wherein at least one of the probe and the target substance is a nucleic acid.
- 5. A method of analyzing a nucleic acid chip comprising a plurality of nucleic acid probes disposed in a matrix pattern on a substrate, the method comprising the steps of:
hybridizing the nucleic acid probes with a target nucleic acid in a sample to form a hybrid; and simultaneously analyzing the nucleic acid probes and the target nucleic acid in the state of the hybrid, wherein the nucleic acid probes and the target nucleic acid are labeled with marker substances of different prescribed numbers and then analyzing the individual marker substances by the Time-of-Flight Secondary Ion Mass Spectrometry, thereby analyzing the labeled nucleic acid probe and the labeled target nucleic acid.
- 6. The method according to claim 5, which comprises selecting and using, as the marker substances, substances capable of generating secondary ions that are distinctly distinguishable from secondary ions derived from a substance constituting the nucleic acid probe and a substance constituting the target nucleic acid.
- 7. The method according to claim 1, wherein the analysis by the Time-of-Flight Secondary Ion Mass Spectroscopy is a quantitative analysis.
- 8. The method according to claim 6, wherein the marker substances comprise halogen atoms, and the nucleic acid probes and the target nucleic acid are labeled with different halogen atoms of prescribed numbers.
- 9. The method according to claim 4, comprising sequentially pulse-irradiating entirely an analysis region of the carrier or the nucleic acid chip with primary ions as a spot having a relatively small area than the area of the analysis region; and subjecting secondary ions generated by the pulse-irradiation to time-of-flight mass spectroscopy for every pulse irradiation to effect imaging.
- 10. The method according to claim 9, wherein the pulse-irradiation with the primary ions is carried out based on a non-continuous pattern, and the results of the respective mass spectroscopic analysis obtained are reconstruction based on the non-continuous pattern of the pulse-irradiation with the primary ions to effect imaging.
- 11. The method according to claim 10, wherein the non-continuous pattern is a random pattern.
- 12. The method according to claim 11, wherein the non-continuous pattern is a specifically programmed pattern.
- 13. The method according to claim 4, wherein the halogen atom is any one of fluorine, chlorine, bromine and iodine atoms.
- 14. The method according to claim 8, wherein the prescribed numbers of the halogen atoms for labeling the nucleic acid probes and the target nucleic acid are each within the range from 1 to the number of nucleotides constituting the nucleic acid probes and the target nucleic acid.
- 15. The method according to claim 14, wherein the prescribed number of the halogen atom is 1 to 5.
- 16. The method according to claim 4, wherein the halogen atom is bonded to at least one of the nucleotide bases of the nucleic acid probe and of the target nucleic acid.
- 17. The method according to claim 16, wherein the halogen atom is bonded at a position not inhibiting the nucleic acid probe from being hybridized when hybridizing the nucleic acid probe with the target nucleic acid.
- 18. The method according to claim 17, wherein the halogen atom is bonded at the 5-position of a pyrimidine base or the 8-position of a purine base.
- 19. The method according to claim 18, wherein the at least one of the nucleic acid probe and the target nucleic acid is a synthetic DNA, and the halogen atom is introduced into the synthetic DNA using 2′-deoxyribonucleoside-3′-phosphoroamidite as a synthetic unit having the halogen atom bonded thereto upon synthesis of the synthetic DNA using an automatic DNA synthesizer.
- 20. The method according to claim 18, wherein the synthetic unit having the halogen atom bonded thereto is represented by one of the following structural formulas:
- 21. The method according to claim 18, wherein the at least one of the nucleic acid probe and the target nucleic acid is a synthetic-RNA, and the halogen atom is introduced into the synthetic RNA using ribonucleoside-3′-phosphoroamidite as a synthetic unit having the halogen atom bonded thereto upon synthesis of the synthetic RNA using an automatic RNA synthesizer.
- 22. The method according to claim 18, wherein the at least one of the nucleic acid probe and the target nucleic acid is a synthetic PNA, and the halogen atom is introduced into the synthetic PNA using a nucleic acid base-bonded peptide analogue as a synthetic unit having the halogen atom bonded thereto upon synthesis of the synthetic PNA using an automatic PNA synthesizer.
- 23. The method according to claim 18, wherein the at least one of the nucleic acid probe and the target nucleic acid is a cDNA, and the halogen atom is introduced into the cDNA using 2′-deoxyribonucleoside-5′-triphosphate having the halogen atom bonded thereto upon synthetic elongation of the cDNA using reverse transcriptase.
- 24. The method according to claim 14, wherein the at least one of the nucleic acid probe and the target nucleic acid is a DNA derived from a genome DNA, and the halogen atom is introduced into the DNA using 2′-deoxyribonucleoside-5′-triphosphate having the halogen atom bonded thereto upon synthetic elongation of the DNA with DNA polymerase.
- 25. The method according to claim 18, wherein the at least one of the nucleic acid probe and the target nucleic acid is a cRNA, and the halogen atom is introduced into the cRNA using ribonucleoside-5′-triphosphate having the halogen atom bonded thereto upon synthetic elongation of the cRNA with RNA polymerase.
- 26. The method according to claim 14, wherein the at least one of the nucleic acid probe and the target nucleic acid is a DNA derived from cDNA, and the halogen atom is introduced into the DNA using 2′-deoxyribonucleoside-5′-triphosphate having the halogen atom bonded thereto upon synthetic elongation of the DNA with DNA polymerase.
- 27. The method according to claim 9, wherein at least one of the marker substances for labeling the nucleic acid probe and the target nucleic acid, respectively, is a metal or a metallic compound.
- 28. The method according to claim 22, wherein the metal element of the metal or metallic compound is selected from the group consisting of Au, Ag, Cu, Ni, Co, Cr, Al, Ta, Pt, Pd, Zn, Sn, Ru and Rh.
- 29. The method according to claim 22, wherein the metallic compound is an organic metal complex.
- 30. The method according to claim 29, wherein the organic metal complex is a comples containing a metal element selected from the group consisting of Au, Ag, Cu, Ni, Co, Cr, Al, Ta, Pt, Pd, Zn, Sn, Ru and Rh.
- 31. The method according to claim 5, comprising sequentially pulse-irradiating entirely an analysis region of the carrier or the nucleic acid chip with primary ions as a spot having a relatively small area than the area of the analysis region; and subjecting secondary ions generated by the pulse-irradiation to time-of-flight mass spectroscopy for every pulse irradiation to effect imaging.
- 32. The method according to claim 31, wherein the pulse-irradiation with the primary ions is carried out based on a non-continuous pattern, and the results of the respective mass spectroscopic analysis obtained are reconstruction based on the non-continuous pattern of the pulse-irradiation with the primary ions to effect imaging.
- 33. The method according to claim 32, wherein the non-continuous pattern is a random pattern.
- 34. The method according to claim 33, wherein the non-continuous pattern is a specifically programmed pattern.
- 35. The method according to claim 31, wherein at least one of the marker substances for labeling the nucleic acid probe and the target nucleic acid, respectively, is a metal or a metallic compound.
Priority Claims (3)
Number |
Date |
Country |
Kind |
2002-190019 |
Jun 2002 |
JP |
|
2002-191391 |
Jun 2002 |
JP |
|
2002-191414 |
Jun 2002 |
JP |
|
Parent Case Info
[0001] This application is a continuation of International Application No. PCT/JP03/08104, filed on Jun. 26, 2003, which claims the benefit of Japanese Patent Application Nos. as follows:
[0002] 1) 2002-190010 filed on Jun. 28, 2002
[0003] 2) 2002-191391 filed on Jun. 28, 2002
[0004] 3) 2002-191414 filed on Jun. 28, 2002
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/JP03/08104 |
Jun 2003 |
US |
Child |
10744730 |
Dec 2003 |
US |